- $28.81bn
- $34.70bn
- $9.84bn
- 86
- 49
- 44
- 61
Annual cashflow statement for Biogen, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 5,889 | 4,061 | 1,728 | 2,962 | 1,162 |
| Depreciation | |||||
| Deferred Taxes | |||||
| Non-Cash Items | 243 | -250 | 1,997 | -1,037 | 845 |
| Unusual Items | |||||
| Purchased R&D | |||||
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 199 | -187 | -146 | -890 | -649 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Accrued Expenses | |||||
| Change in Taxes Payable | |||||
| Change in Other Liabilities | |||||
| Net Change in Other Assets & Liabilities | |||||
| Cash from Operating Activities | 7,079 | 4,230 | 3,640 | 1,384 | 1,547 |
| Capital Expenditures | -670 | -552 | -295 | -243 | -311 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | 1,140 | -56.8 | -269 | 1,820 | -3,790 |
| Acquisition of Business | |||||
| Sale of Business | |||||
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | 471 | -609 | -564 | 1,577 | -4,101 |
| Financing Cash Flow Items | 7.9 | -61 | -116 | 4.9 | -38 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -5,860 | -5,273 | -2,086 | -1,747 | 149 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 1,689 | -1,583 | 930 | 1,158 | -2,369 |